sulfathiazole has been researched along with Lupus Erythematosus, Systemic in 1 studies
Sulfathiazole: A sulfathiazole compound that is used as a short-acting anti-infective agent. It is no longer commonly used systemically due to its toxicity, but may still be applied topically in combination with other drugs for the treatment of vaginal and skin infections, and is still used in veterinary medicine.
sulfathiazole : A 1,3-thiazole compound having a 4-aminobenzenesulfonamido group at the 2-position.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BAUER, J | 1 |
| ARNDAL, O | 1 |
1 other study available for sulfathiazole and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Arthritic syndromes; Reiter's disease followed by endocarditis and lupus erythematosus disseminatus after sulfathiazole treatment.
Topics: Arthritis; Arthritis, Reactive; Endocarditis; Humans; Lupus Erythematosus, Systemic; Sulfathiazole; | 1946 |